Copyright
©The Author(s) 2024.
World J Gastroenterol. Feb 14, 2024; 30(6): 565-578
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.565
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.565
Figure 4 JOSD2 knockdown significantly suppresses the activity of esophageal squamous cell carcinoma cells.
A: JOSD2 was successfully knocked down using shRNA1/2 directed against JOSD2 in KYSE150 cells; B: JOSD2 knockdown significantly inhibited cell proliferation; C: JOSD2 knockdown significantly inhibited the ability of the cells to form colonies. cP < 0.0001.
- Citation: Wang WP, Shi D, Yun D, Hu J, Wang JF, Liu J, Yang YP, Li MR, Wang JF, Kong DL. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma. World J Gastroenterol 2024; 30(6): 565-578
- URL: https://www.wjgnet.com/1007-9327/full/v30/i6/565.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i6.565